Advancing a multi-asset pipeline of high-impact therapeutic solutions

Our pipeline is comprised of innovative therapeutic products that have the potential for optimized value creation using our partnership-enabled business model.

Our flagship product candidates, Virtue SAB and BackBeat CNT, exemplify key criteria that characterize innovations optimized for strategic partnerships:

Target large therapeutic device markets with significant unmet needs
Provide high impact procedure-based solutions with rapid adoption potential
Offer strategic and financial benefits to commercial partners

Virtue SAB - Video